Keywords: verxve, study, once-daily, viramune, german, drug, major

VERXVE study to test once-daily Viramune

Article | 18 February 2008

Print This

German drug major Boehringer Ingelheim has initiated and begun enrollment of patients in the VERXVE trial, which will compare the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in